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Abstract 
Purpose: To investigate the effects of chronic intake of a brand of energy drink (ED) on the liver and 
kidney of rats.  
Methods: Sixty male adult Sprague Dawley albino rats were randomly assigned to four groups (15 rats 
per group). Three groups received ED at different doses (0.4, 1.1 and 2.2 ml/100 g body weight/day) for 
12 weeks. The fourth group (control) received distilled water. All treatments were administered by oral 
gavage. Blood samples were withdrawn at the start of the experiment, and at the 6th and 12th weeks for 
assay of hepatic and renal biochemical parameters. Histopathological studies were done at the end of 
the exposure period.  
Results: Exposure to ED doses of 1.1 and 2.2 ml/100g body weight/day for 12 weeks induced highly 
significant increases in serum aspartate transaminase (AST), alanine transaminase (ALT), alkaline 
phosphatase (ALP), blood urea nitrogen (BUN), creatinine and uric acid, when compared with the 
control group (p < 0.001). On the other hand, the activities of the antioxidant enzymes, viz, superoxide 
dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) significantly decreased (p < 0.001) 
by exposure to these two ED doses, relative to controls. Pronounced histopathological changes were 
observed in hepatic and renal tissues of the ED-treated rats. 
Conclusion: Oral exposure of rats to ED for 12 weeks produced noticeable hepatic and renal damage, 
probably due to increased free radical production and oxidative stress. 
 
Keywords: Energy drink, Reactive oxygen species, Liver function, Kidney function, Histopathological 
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First appearance of energy drinks (EDs) was in 
Europe and Asia in the 1960 as a result of 
customer requirements for dietary supplements 
that give energy [1]. Many Saudi studies found 
that more than half of the consumers were 
young (13 - 35 years old), more than half 
consumed it for over a year, and over 40 % 
used to drink more than 3 cans per week [2]. 
Centers for Disease Control and Prevention 
reported that high school students consume 
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EDs almost at the same rate as they consume 
soda [1]. Indeed, the rate of ED consumption 
might be higher than estimated levels in this 
self-reporting survey, since such surveys 
usually have high probability of under-
estimation. 
 
It has been revealed that EDs contain mainly 
taurine, glucuronolactone, caffeine, ginseng 
and guarana [3]. These substances, most of 
which act as stimulants, are not included in the 
list of materials under regulation by the Food 
and Drug Administration (FDA) of the United 
States of America. The levels of these 
stimulants vary amongst different brands of 
EDs, and in most cases, are higher than values 
allowable [4].  A study has shown that the 
caffeine levels in EDs are between 50 and 505 
mg/ can, which are much higher than the 
caffeine content of one can of Coke (34 mg) [5]. 
 
Reports of significant, adverse health problems 
due to ingestion of EDs have increased in 
recent years. Indeed, in 2013, ED-associated 
emergency interventions by the US Substance 
Abuse and Mental Health Services 
Administration doubled from 10,068 in 2017 to 
over 20,000 in 2011 [6].  A major constraint in 
understanding the link between EDs and the 
adverse effects of their consumption is that very 
little is known about the toxicity of the various 
compounds present in them. However, based 
on reported cases of ED-associated health 
problems, and the well-established 
physiological effects of the active ingredients of 
EDs, it is very likely that the observed adverse 
effects of EDs are linked to their compositions 
[3]. Due to the aforementioned reasons we 
purposed this study to explore the toxic effects 
of prolonged intake of ED on hepatic and renal 






The brand of ED used in the present study was 
“Red bull”, product of Rauch Trading AG, 
Switzerland (manufactured for Red Bull GmbH, 
Austria). It was purchased from a local store in 




Sixty (60) adult, male Sprague Dawley rats 
(mean weight = 115.5g) were kept in the Animal 
House of College of Pharmacy, King Saud 
University. The rats were acclimatized under a 
12h/12h light/dark photoperiod and under normal, 
healthy laboratory conditions at a mean 
temperature of 25 ± 2 °C. The experiments were 
carried out in line with the recommendations of 
International Laboratory Animal Use and Care 
[7]. The study protocols and ethics were 
approved by the Animal Research and Ethical 
Committee of King Saud University (approval No. 




Four (4) groups of rats were used (15 
rats/group). There was no bias in the allocation 
of rats to any group. Rats in the control group 
(G1) were maintained on the basal diet and 
distilled water throughout the experiment. Three 
levels of ED exposure were used: mild, 
moderate and high ED. Rats in the mild ED 
intake group (G2) was given low dose of ED 
(0.4 ml / 100 g body weight / day) to simulate 
low human consumption pattern (280 ml/ED 
can), while the moderate ED group (G3) 
received 1.1 ml /100g body weight / day, to 
reflect moderate human consumption level of 
770ml (about 3 cans of ED). The high ED intake 
group (G4) was given 2.2 ml/100 g body 
weight/day to mimic estimated high human 
consumption level of 1540 ml (about six cans). 
All treatments were given by gavage, and 




Prior to the commencement of ED exposure, 
blood samples were taken from the retrobulbar 
venous plexus for the determination of various 
basal biochemical parameters. Blood samples 
were also drawn through the same route at the 
6th week (mid-way) and at the end (12th week), 
for similar assays. The samples were allowed to 
coagulate and the sera were stored at -20 °C 
prior to assay of AST, ALT, BUN and ALP. 
Moreover, plasma samples from blood collected 
in anticoagulant bottles were frozen at – 20 °C 
and used for assay of CAT activity. The pellet 
(erythrocytes) was washed thrice in 3 mL of 
physiological saline, and centrifuged for 10 min 
at 3000 x g. The erythrocytes were thereafter 
hemolyzed with 1.5 volume of distilled water, 
and the hemolysate was clarified by 
centrifugation for 15 min at 10,000 x g and 4 oC. 
The resultant supernatant was used for the 
assay of the activities of the antioxidant 
enzymes GPx and SOD. 
 
Histological examination  
 
Blood samples were taken at the expiration of 
week 12, and all rats were sacrificed by 
decapitation. Liver and kidney samples were 
immediately excised and processed for light 
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microscopy and histological investigation using 
standard methods. Specimens were fixed in 10 





The activities of ALT, ALP and AST, and the 
levels of creatinine, BUN and uric acid were 
measured colorimetrically using Randox UV 
kinetic method kits (Randox, USA) in line with 
the manufacturer’s protocol [8]. Plasma 
catalase (CAT) and erythrocyte SOD and GPx 
activities were also assayed colorimetrically 
using Randox assay kits (Randox, USA) 
according to the procedures specified by the kit 




Data are presented as mean ± SE. One-way 
analysis of variance (ANOVA) was used for 
assessing differences among groups. This was 
followed by Bonferroni post-hoc paired 
comparison using Windows SPSS version 20.0 
(SPSS Inc., Chicago IL, USA). P < 0.05 was 







Rats treated with either moderate or high doses 
of ED had significant increases in serum AST, 
ALT and ALP levels at weeks 6 and 12 of the 
experimental period, when compared with their 
baseline levels and corresponding levels in the 
control group.  These results are shown in 




The effects of the three doses of ED on kidney 
function of rats are presented in Tables 4, 5 and 
6. Rats exposed to high doses of ED had 
significant increases in serum creatinine, BUN 
and uric acid levels at week 12 when compared 
with the baseline levels of these parameters, and 
the corresponding values in the control group. 
 
Activity of antioxidant enzymes 
 
The effect of the three doses of ED on levels of 
some antioxidant enzymes in rats are 
presented in Tables 7, 8 and 9.  Exposure to 
high dose of ED led to significant decreases in 
SOD, GPx and CAT activities at 12 weeks of 
the experimental period, relative to their 
baseline levels and the corresponding levels in 




The general architecture of the liver and the 
kidneys in G4 were distorted with congestion of 
central and portal veins and inflammation of 
portal areas as shown in Figure 1 I. Proliferation 
of bile ducts and starting fibrosis appears in 
Figure 1 II.  
 
Table 1: Serum AST (U/L) levels of rats treated daily by different concentrations of energy drinks for 12 weeks 
 
Group  Duration of consumption P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
66.20±4.551 
68.60±4.70a1 67.77±3.81a1 0.83 
Group 2:(0.4 ml/100g/day) 78.21±4.76ab12 91.21±4.76b2 0.001 
Group 3:(1.1 ml/100g/day) 93.43±6.91b2 122.69±6.86c3 0.001 
Group 4:(2.2 ml/100g/day) 128.57±6.83c2 190.62±3.61d3 0.001 
P-value 1.00 0.001 0.001  
Data are expressed as mean ± SE (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
 
Table 2: Serum ALT (U/L) levels of rats treated daily by different concentrations of energy drinks for 12 weeks 
 
Group  Duration of consumption P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
45.27±2.471 
54.27±4.62a2 58.92±3.99a2 0.04 
Group 2:(0.4 ml/100g/day) 59.09±2.66a2 66.27±3.45a2 0.001 
Group 3:(1.1 ml/100g/day) 61.94±4.23a2 69.13±4.39a2 0.001 
Group 4:(2.2 ml/100g/day) 90.79±6.73b2 107.80±7.90b2 0.001 
P-value 1.00 0.001 0.001  
Data are expressed as mean ± SE   (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
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Table 3: Serum ALP (U/L) levels of rats treated daily by different concentrations of energy drinks for 12 weeks 
 
Group  
Duration of consumption 
P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
137.27±18.201 
142.40±11.37a1 133.69±8.71a1 0.91 
Group 2:(0.4 ml/100g/day) 158.64±9.16ab1 182.64±9.16b1 0.06 
Group 3:(1.1 ml/100g/day) 200.29±11.62b2 237.00±12.41c2 0.001 
Group 4:(2.2 ml/100g/day) 300.86±15.70c2 421.69±18.25d3 0.001 
P-value 1.00 0.001 0.001  
Data are expressed as mean ± SE (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
 




Duration of consumption 
P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
0.33±0.021 
0.43±0.03a12 0.45±0.03a2 0.02 
Group 2:(0.4 ml/100g/day) 0.45±0.02a2 0.53±0.02ab2 0.001 
Group 3:(1.1 ml/100g/day) 0.47±0.02ab2 0.58±0.05b2 0.001 
Group 4:(2.2 ml/100g/day) 0.57±0.04b2 0.73±0.03c3 0.001 
P-value 1.00 0.001 0.001  
Data are expressed as mean ± SE (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
 




Duration of consumption 
P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
7.57±0.551 
10.23±0.33a2 8.68±0.44a12 0.84 
Group 2:(0.4 ml/100g/day) 10.60±0.48a2 11.54±0.48b2 0.001 
Group 3:(1.1 ml/100g/day) 18.70±0.60b2 19.79±0.64c2 0.001 
Group 4:(2.2 ml/100g/day) 17.41±0.59b2 23.48±0.63d3 0.001 
P-value 1.00 0.001 0.001  
Data are expressed as mean ± SE   (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
 




Duration of consumption 
P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
2.37±0.101 
2.41±0.21a1 2.31±0.19a1 0.84 
Group 2:(0.4 ml/100g/day) 2.57±0.10a2 2.71±0.11b3 0.001 
Group 3:(1.1 ml/100g/day) 3.07±0.12b2 3.28±0.13c2 0.001 
Group 4:(2.2 ml/100g/day) 3.46±0.15b2 3.89±0.16d3 0.001 
P-value 1.00 0.001 0.001  
Data are expressed as mean ± SE (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
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Table 7: Superoxide dismutase (SODs, units/mL) level in erythrocytes of male rats orally and daily 
administrated different concentration of energy drinks for 12 weeks 
 
Group  Duration of consumption P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
0.20±0.021 
0.22±0.02a1 0.23±0.02a1 0.75 
Group 2:(0.4 ml/100g/day) 0.21±0.02a1 0.21±0.02a1 0.99 
Group 3:(1.1 ml/100g/day) 0.20±0.01a1 0.19±0.01a1 0.77 
Group 4:(2.2 ml/100g/day) 0.17±0.01a1 0.09±0.01b2 0.001 
P-value 1.00 0.26 0.001  
Data are expressed as mean ± SE (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
 
Table 8: Glutathione Peroxidase (nmol/min/mL) level in erythrocyte of rats treated daily by different 
concentrations of energy drinks for 12 weeks 
 
Group  Duration of consumption P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
80.30±1.451 
78.91±2.08a1 77.30±1.45a1 0.47 
Group 2:(0.4 ml/100g/day) 76.07±1.98a12 73.92±0.85a2 0.02 
Group 3:(1.1 ml/100g/day) 56.31±3.19b2 53.40±3.19b2 0.001 
Group 4:(2.2 ml/100g/day) 45.86±2.49c2 42.69±2.41c2 0.001 
P-value 1.00 0.001 0.001  
Data are expressed as mean ± SE (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p<0.05); mean values not sharing a superscript digit in a row indicate significant difference at p 
< 0.05 
 
Table 9: Plasma catalase (nmol/min/mL) level of rats treated daily by different concentrations of energy drinks for 
12 weeks 
 
Group  Duration of consumption P-value Initial Half-way (6 weeks) End (12 weeks) 
Group 1:(control) 
14.78±1.181 
15.69±1.40a1 14.82±1.37a1 0.86 
Group 2:(0.4 ml/100g/day) 14.46±1.31a1 13.20±0.99a1 0.61 
Group 3:(1.1 ml/100g/day) 13.96±1.28a1 12.97±1.29a1 0.60 
Group 4:(2.2 ml/100g/day) 12.74±0.83a12 10.17±0.73a2 0.01 
P-value 1.00 0.45 0.07  
Data are expressed as mean ± SE (n = 15); mean values with different alphabet superscripts within a column 
differ significantly (p < 0.05); mean values not sharing a superscript digit in a row indicate significant difference 
at p < 0.05 
 
Marked dilatation and congestion of veins and 
severe inflammation of the interstitial as shown 
in Figure 1 III. Remnants of destroyed tubules 
were seen within areas of inflammation with 
signs of degeneration, necrosis, loss of cellular 





This study has demonstrated that oral 
administration of ED to rats for 12 weeks 
resulted in varying degrees of liver and kidney 
damage. This was evident in the ED-induced 
significant elevations in serum AST, ALT and 
ALP, creatinine, BUN and uric acid levels. 
Increases in the blood levels of hepatic enzymes 
serve as reliable indicators of liver damage by 
toxic agents. Similar increases have been 
reported in serum AST, ALT and ALP of rats 
exposed to caffeinated EDs [11]. It has been 
demonstrated that rats administered ED alone or 
in combination with alcohol showed higher 
serum total bilirubin, ALT, ALP and AST than 
untreated controls [12]. 
 
In the present study, serum uric acid and 
creatinine concentrations were significantly 
increased in ED-treated rats. Increases in blood 
levels of uric acid and creatinine are usually 
associated with impaired kidney function [13]. 
These results are in agreement with the findings 
of Khayyat and his colleagues who reported that 
EDs induced elevations in serum urea, uric acid 
and creatinine [14]. These researchers 
suggested that caffeine induced the elevations 
in urea, uric acid and creatinine through 
inhibition of A2A adenosine receptors, resulting 
in the development of interstitial inflammation, 
increased proteinuria and deleterious changes in 
renal function and structure [14].  
 






Figure 1: Light micrographs of liver (I and II) and 
kidney (III and IV) sections of rat in G 4 (highest ED-
exposed group). Specimens were fixed in 10% 
neutral formalin and stained with H & E, 
magnification 100 μm. I:   Showing a markedly 
dilated and congested portal vein (PV). The portal 
area shows starting fibrosis (F), inflammatory 
cellular infiltration (I), and bile duct proliferation 
(asterisks). Hepatocytes at the periphery of the 
lobules show undergoing degeneration and necrosis 
with shrunken or disappearing nuclei (arrows). II: 
Showing distorted general architecture of the liver, 
congestion of a portal vein (PV) and inflammation (I) 
in portal areas as well as between hepatocytes 
which also show marked vacuolation mainly at the 
peripheries of lobules (arrows). III: Showing 
distorted general architecture, marked dilatation and 
congestion of veins (V) and severe inflammation of 
the interstitial tissue (I). Some renal corpuscles are 
reduced in size with narrowing of the urinary space 
(arrows). IV: Showing a markedly dilated vein (V), a 
renal corpuscle with a markedly shrunken 
glomerulus (G) and a markedly widened urinary 
space (asterisk). The renal corpuscle is surrounded 
by starting Fibrosis (F). The tubular cells show signs 
of degeneration and necrosis with loss of cellular 
details and cell boundaries (arrows) 
 
However, some other ED-based studies 
reported findings that are at variance with these 
results. For example, it has been reported that 
consumption of EDs was associated with higher 
plasma total protein and lowered levels of 
creatinine, albumin and uric acid [16]. Yet other 
researchers found no significant association 
between caffeine intake and the serum levels of 
urea and creatinine in rats [17]. These 
disparities on the effect of ED may be attributed 
to lack of uniformity in the composition of these 
energy beverages.  
 
The present study also revealed that ED 
exposure led to increased oxidative stress in the 
rats. This was evident in the ED-induced 
significant decreases in activities of SOD, CAT 
and GPx. These enzymes are important 
antioxidants which work in concert with the non-
enzymatic antioxidant system to protect cells 
from oxidative damage by free radicals [18]. 
Indeed, the antioxidant enzymes are the first line 
of defense which protects cells from oxidative 
stress-induced damage. Superoxide dismutase 
(SOD) neutralizes the highly reactive superoxide 
anion by converting it to hydrogen peroxide, 
which is in turn degraded to water by GPx and 
CAT [19]. The significant reductions in blood 
levels of these enzymes, especially in the rats 
that received medium and high doses of ED, 
might be due to ED-induced increases in 
superoxide radical, thereby overwhelming the 
neutralizing capacities of the antioxidant 
enzymes.  
 
Studies have shown that exposure of human 
cells to high levels of caffeine induced a pro-
oxidant environment in the cells, leading to 
increased protein oxidation, while low levels of 
caffeine had no effect on the antioxidant 
capacity of cells [20]. It has been demonstrated 
that caffeine significantly increased BUN levels, 
resulting in the activation of xanthine oxidase 
which in turn, stimulated the oxidation of 
xanthine to uric acid, and generation of 
superoxide anion and H2O2 [21]. The interaction 
between H2O2 with O2 produces free radicals. 
On the other hand, several studies have 
independently demonstrated the antioxidant 
properties of many components of ED such as 
taurine, ginseng, caffeine and guarana [21].  
 
The pattern of variations seen in liver and kidney 
function parameters of rats exposed to the 
different doses of ED was in agreement with the 
lesions in the photomicrographs of these 
tissues. The observed lesions are most likely a 
consequence of the deleterious effects of ED. It 
can be reasonably suggested that the lesions 
were brought about by tissue damage arising 
from ED-induced oxidative stress. These results 
are consistent with a previous report on 
evidence of hepatotoxicity and alterations in liver 
ultrastructure in rats treated with different types 
of EDs [22]. In another study, the lesions in liver 
and kidney tissues were attributed to potential 
reaction of taurine with some other active ED 
ingredient such as caffeine [23]. In addition, 
Khayyat and his colleagues found that rats 
treated with EDs had hepatic cytoplasmic 
vacuolations due to presence of lipid droplets 
which were attributed to deteriorative changes 
within hepatocytes [22]. 
 
Many investigators are in agreement on the 
adverse effects of ED as obtained in the present 
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study [11]. However, others reported that Power 
Horse and Red Bull significantly influenced liver 
enzyme activities but had no significant 
influence liver histopathology [16]. Some 
researchers reported irregular outlines and 
pyknosis in the nuclei of hepatocytes, and 
numerous mitotic figures [17].These changes 
may be attributed to the toxic effects of caffeine, 
and the harmful effects of preservative 
substances added to EDs, such as sodium 
benzoate [24]. However, it has been reported 
that ED-induced hepatocyte damage was 
reversible as indicated by blood chemistry 
analysis and histopathological studies of the 




The results of this study demonstrate that 
exposure of rats to high doses of Red bull for 12 
weeks leads to liver and kidney damage. The 
pronounced reduction in the blood levels of key 
antioxidant enzymes suggests that the harmful 
effects of Red bull are mediated through 
increased ROS generation and oxidative stress. 
If animal-to-man extrapolation is permitted, these 
results call for restraint and caution in the 
consumption of Red bull and other EDs. Thus, 
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